{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T22:55:48Z","timestamp":1765666548883,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009757","name":"National Institute of Advanced Industrial Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009757","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001695","name":"Japan Science and Technology Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001695","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1006\/jaut.2001.0559","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T14:37:32Z","timestamp":1033915052000},"page":"9-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Anti-CD44 Monoclonal Antibody (IM7) Induces Murine Systemic Shock Mediated by Platelet Activating Factor"],"prefix":"10.1006","volume":"18","author":[{"given":"Yasuo","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Makiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youji","family":"Mitsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/jaut.2001.0559_RF1","doi-asserted-by":"crossref","first-page":"D616","DOI":"10.2741\/A306","article-title":"CD44 structure and function","volume":"3","author":"Lesley","year":"1998","journal-title":"Front Biosci"},{"key":"10.1006\/jaut.2001.0559_RF2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1126\/science.278.5338.672","article-title":"Requirement for CD44 in activated T cell extravasation into an inflammatory site","volume":"278","author":"DeGrendele","year":"1997","journal-title":"Science."},{"key":"10.1006\/jaut.2001.0559_RF3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/mp.51.4.191","article-title":"The normal structure and function of CD44 and its role in neoplasia","volume":"51","author":"Sneath","year":"1998","journal-title":"Mol. Pathol."},{"key":"10.1006\/jaut.2001.0559_RF4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1357-2725(97)00152-0","article-title":"The CD44 protein family","volume":"30","author":"Ponta","year":"1998","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"10.1006\/jaut.2001.0559_RF5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/9518","article-title":"Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia","volume":"5","author":"Charrad","year":"1999","journal-title":"Nat. Med."},{"key":"10.1006\/jaut.2001.0559_RF6","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1172\/JCI119026","article-title":"CD44: one ligand, two functions","volume":"98","author":"Aruffo","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1006\/jaut.2001.0559_RF7","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nm0695-558","article-title":"Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis","volume":"1","author":"Mikecz","year":"1995","journal-title":"Nat. Med."},{"key":"10.1006\/jaut.2001.0559_RF8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1073\/pnas.97.1.285","article-title":"Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody","volume":"97","author":"Weiss","year":"2000","journal-title":"Proc. Natl Acad. Sci USA"},{"key":"10.1006\/jaut.2001.0559_RF9","doi-asserted-by":"crossref","first-page":"6896","DOI":"10.1073\/pnas.96.12.6896","article-title":"Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment","volume":"96","author":"Brocke","year":"1999","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1006\/jaut.2001.0559_RF10","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.4049\/jimmunol.142.6.2046","article-title":"Monoclonal antibodies against the CD44 [In(Lu)-related p80], and Pgp-1 antigens in man recognize the Hermes class of lymphocyte homing receptors","volume":"142","author":"Picker","year":"1989","journal-title":"J. Immunol."},{"key":"10.1006\/jaut.2001.0559_RF11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF00364338","article-title":"Biochemical characterization and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed on lymphoid tissues","volume":"15","author":"Trowbridge","year":"1982","journal-title":"Immunogenetics"},{"key":"10.1006\/jaut.2001.0559_RF12","doi-asserted-by":"crossref","first-page":"7877","DOI":"10.1073\/pnas.88.17.7877","article-title":"T-cell-receptor-independent activation of cytolytic activity of cytotoxic T lymphocytes mediated through CD44 and gp90MEL-14","volume":"88","author":"Seth","year":"1991","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1006\/jaut.2001.0559_RF13","series-title":"Antibodies","article-title":"Digesting antibodies with pepsin to isolate F(ab)2 fragments","author":"Harlow","year":"1988"},{"key":"10.1006\/jaut.2001.0559_RF14","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1248\/bpb.19.1112","article-title":"Quantitative evaluation of passive cutaneous anaphylaxis (PCA) using a hand-held spectrophotometer","volume":"19","author":"Akiyama","year":"1996","journal-title":"Biol. Pharm. Bull."},{"key":"10.1006\/jaut.2001.0559_RF15","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1248\/bpb.20.714","article-title":"A novel method for induction and detection of anaphylactic reaction using the mouse abdominal wall (AW method)","volume":"20","author":"Kataoka","year":"1997","journal-title":"Biol. Pharm. Bull."},{"key":"10.1006\/jaut.2001.0559_RF16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000233873","article-title":"Pharmacological characterization of mouse ear PCA","volume":"78","author":"Inagaki","year":"1985","journal-title":"Int. Arch Allergy Appl. Immunol."},{"key":"10.1006\/jaut.2001.0559_RF17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF01741408","article-title":"Investigations into the route of uptake and pharmacokinetics of intraperitoneally-administered monoclonal antibodies: I. Transdiaphragmatic blockade of the terminal lymphatics in the rat","volume":"31","author":"Barrett","year":"1990","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1006\/jaut.2001.0559_RF18","first-page":"3434","article-title":"Effect of intraperitoneal injection volume and antibody protein dose on the pharmacokinetics of intraperitoneally administered IgG2a kappa murine monoclonal antibody in the rat","volume":"51","author":"Barrett","year":"1991","journal-title":"Cancer Res."},{"key":"10.1006\/jaut.2001.0559_RF19","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/0006-291X(84)91380-9","article-title":"Platelet activating factor intravenous infusion in rats stimulates vascular lysosomal hydrolase secretion independent of blood neutrophils","volume":"125","author":"Doebber","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/jaut.2001.0559_RF20","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0090-6980(90)90001-C","article-title":"Pharmacological actions of Y-24180: I. A potent and specific antagonist of platelet-activating factor","volume":"40","author":"Terasawa","year":"1990","journal-title":"Prostaglandins."},{"key":"10.1006\/jaut.2001.0559_RF21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0162-3109(82)90019-4","article-title":"Vascular actions of synthetic PAF-acether (a synthetic platelet-activating factor) in the rat: evidence for a platelet independent mechanism","volume":"4","author":"Sanchez-Crespo","year":"1982","journal-title":"Immunopharmacology."},{"key":"10.1006\/jaut.2001.0559_RF22","first-page":"H25","article-title":"Effects of PAF and BN 52021 on cardiac function and regional blood flow in conscious rats","volume":"257","author":"Siren","year":"1989","journal-title":"Am. J. Physiol."},{"key":"10.1006\/jaut.2001.0559_RF23","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.4049\/jimmunol.136.12.4554","article-title":"Administration of monoclonal anti-T cell antibodies retards murine lupus in BXSB mice","volume":"136","author":"Wofsy","year":"1986","journal-title":"J. Immunol."},{"key":"10.1006\/jaut.2001.0559_RF24","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/00007890-199004000-00009","article-title":"In vivo cell activation following OKT3 administration. Systemic cytokine release and modulation by corticosteroids","volume":"49","author":"Chatenoud","year":"1990","journal-title":"Transplantation"},{"key":"10.1006\/jaut.2001.0559_RF25","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/00007890-199010000-00023","article-title":"Reduction of morbidity and cytokine release in anti-CD3 MoAb-treated mice by corticosteroids","volume":"50","author":"Ferran","year":"1990","journal-title":"Transplantation"},{"key":"10.1006\/jaut.2001.0559_RF26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/brain\/119.1.225","article-title":"Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis","volume":"119","author":"Moreau","year":"1996","journal-title":"Brain"},{"key":"10.1006\/jaut.2001.0559_RF27","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.4049\/jimmunol.158.7.3148","article-title":"CD16 cross-linking induces both secretory and extracellular signal-regulated kinase (ERK)-dependent cytosolic phospholipase A2 (PLA2) activity in human natural killer cells: involvement of ERK, but not PLA2, in CD16-triggered granule exocytosis","volume":"158","author":"Milella","year":"1997","journal-title":"J. Immunol."},{"key":"10.1006\/jaut.2001.0559_RF28","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1083\/jcb.146.4.843","article-title":"Analysis of CD44-containing lipid rafts: Recruitment of annexin II and stabilization by the actin cytoskeleton","volume":"146","author":"Oliferenko","year":"1999","journal-title":"J. Cell Biol."},{"key":"10.1006\/jaut.2001.0559_RF29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/08820139809022711","article-title":"Suppressive effects of antihistaminic and\/or anti-PAF agents on passive anaphylactic shock in mice sensitized with allogeneic monoclonal IgE and IgG1 antibodies and hyperimmune serum","volume":"27","author":"Kimura","year":"1998","journal-title":"Immunol. Invest."},{"key":"10.1006\/jaut.2001.0559_RF30","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.4049\/jimmunol.161.6.3026","article-title":"Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16)","volume":"161","author":"Hazenbos","year":"1998","journal-title":"J. Immunol."},{"key":"10.1006\/jaut.2001.0559_RF31","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0022-3565(25)23374-2","article-title":"Inhibition of the platelet activating factor (PAF)-induced in vivo responses in rats by trans-2,5-(3,4,5-trimethoxyphenyl) tetrahydrofuran (L-652,731), a PAF receptor antagonist","volume":"239","author":"Wu","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/jaut.2001.0559_RF32","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1182\/blood.V95.5.1856.005k03_1856_1861","article-title":"Vasoactive side effects of intravenous immunoglobulin preparations in a rat model and their treatment with recombinant platelet-activating factor acetylhydrolase","volume":"95","author":"Bleeker","year":"2000","journal-title":"Blood"},{"key":"10.1006\/jaut.2001.0559_RF33","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/j.1349-7006.1998.tb00511.x","article-title":"CD44H participates in the intrahepatic growth of murine colon 26 adenocarcinoma cells","volume":"89","author":"Ogoshi","year":"1998","journal-title":"Jpn J. Cancer. Res."},{"key":"10.1006\/jaut.2001.0559_RF34","first-page":"1561","article-title":"Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody","volume":"54","author":"Guo","year":"1994","journal-title":"Cancer Res."},{"key":"10.1006\/jaut.2001.0559_RF35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/135245859800400312","article-title":"Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide","volume":"4","author":"Laman","year":"1998","journal-title":"Mult. Scler."},{"key":"10.1006\/jaut.2001.0559_RF36","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.4049\/jimmunol.161.3.1069","article-title":"Curative treatment of an experimentally induced colitis by a CD44 variant V7-specific antibody","volume":"161","author":"Wittig","year":"1998","journal-title":"J. Immunol."},{"key":"10.1006\/jaut.2001.0559_RF37","unstructured":"Mikecz, K. Glant, T.T. 1999, Method of inhibiting tissue destruction in autoimmune disease using anti-CD44 antibodies"},{"key":"10.1006\/jaut.2001.0559_RF38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/jaut.1999.0294","article-title":"CD44 involvement in experimental collagen-induced arthritis (CIA)","volume":"13","author":"Nedvetzki","year":"1999","journal-title":"J. Autoimmun."},{"key":"10.1006\/jaut.2001.0559_RF39","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.4049\/jimmunol.159.7.3613","article-title":"Human IgG2 variants of chimeric anti-CD3 are nonmitogenic to T cells","volume":"159","author":"Cole","year":"1997","journal-title":"J. Immunol."},{"key":"10.1006\/jaut.2001.0559_RF40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/08916939109007648","article-title":"Effects of ginkgolide B, a platelet-activating factor inhibitor on insulitis in the spontaneously diabetic BB rat","volume":"9","author":"Beck","year":"1991","journal-title":"Autoimmunity"},{"key":"10.1006\/jaut.2001.0559_RF41","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/BF01972856","article-title":"An investigation into the possible involvement of platelet activating factor in experimental allergic encephalomyelitis in rats","volume":"27","author":"Howat","year":"1989","journal-title":"Agents Actions"},{"key":"10.1006\/jaut.2001.0559_RF42","first-page":"1080","article-title":"A platelet activating factor receptor antagonist prevents the development of chronic arthritis in mice","volume":"26","author":"Palacios","year":"1999","journal-title":"J. Rheumatol."},{"key":"10.1006\/jaut.2001.0559_RF43","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0002-9440(10)64808-0","article-title":"PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis","volume":"157","author":"Bussolati","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1006\/jaut.2001.0559_RF44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0167-4889(97)00106-7","article-title":"Production, metabolism and effect of platelet-activating factor on the growth of the human K562 erythroid cell line","volume":"1359","author":"Dupuis","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1006\/jaut.2001.0559_RF45","first-page":"2662","article-title":"Augmentation of tumor metastasis by platelet-activating factor","volume":"56","author":"Im","year":"1996","journal-title":"Cancer Res."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841101905591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841101905591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T07:53:19Z","timestamp":1760255599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841101905591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["S0896841101905591"],"URL":"https:\/\/doi.org\/10.1006\/jaut.2001.0559","relation":{},"ISSN":["0896-8411"],"issn-type":[{"type":"print","value":"0896-8411"}],"subject":[],"published":{"date-parts":[[2002,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-CD44 Monoclonal Antibody (IM7) Induces Murine Systemic Shock Mediated by Platelet Activating Factor","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/jaut.2001.0559","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Elsevier Science Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}